We recently reported that cholestyramine (a bile acid se questrant) lowered ileal apolipoprotein A-I mRNA level in rats. To obtain further information about this phenomenon, in this study, we investigated whether bile diversion lowers apolipoprotein A-I mRNA level in the ileum of rats. Bile-diverted rats were fed a diet with no added Na taurocholate (control diet) or with 0.4% Na taurocholate for 7 days. Sham-operated rats were also fed the control diet for the same period. Northern blot analysis revealed that the relative concentrations of jejunal apolipoprotein A-I and A-IV mRNA at the end of experimental period did not differ between groups while ileal apolipoprotein A-I and A-IV mRNA concentrations were significantly lower in bile-diverted rats fed the control and Na taurocholate-containing diets than in sham-operated rats. Plasma total and HDL cholesterol concentrations were the same in all groups. Relative concentration of apolipoprotein A-I in plasma also did not change. These results suggest that the bile plays an important role in ileal apolipoprotein gene expression at the pretranslational stage, but it is still unclear whether the effector is the bile acid or not. The unchanged concentration of plasma apolipoprotein A-I may have resulted from the constant secretion independent of synthesis in the intestine or the larger contribution from the liver which is another principal site for apolipo protein A-I expression.
(apo A-I) and this apolipoprotein is synthesized in both the liver and small intestine (2, 3) . Apo A-I synthesis may be important in the regulation of plasma HDL concentrations (4) .
Recently, we reported that cholestyramine (a bile acid sequestrant) lowered apo A-I mRNA level in the ileum but not the jejunum of rats (5) . Davidson and Glickman (6) showed that apo A-I synthesis in the rat jejunum was regulated in part by the availability of luminal lipid but not by the presence of bile, whereas in the ileum, apo A-I synthesis was related to biliary lipid flux but not to the presence of luminal bile acids. These observations suggest that apo A-I synthesis in the ileum, the principal site for the active transport of bile acids, may be modified by the biliary element at the pretranslational stage. In this study, to obtain further information about this phenomenon, we investigated whether bile diversion lowers apo A-I mRNA level in the ileum, and whether concurrent feeding of Na tauro cholate modifies the effect of bile diversion in rats. Plasma total and HDL cholesterol concentrations at the end of the experimen tal period are shown in Table 2 . They were not significantly changed among three groups. Figure 1 shows representative Western blots of plasma apo A-I which is the main protein component of HDL in rats. The relative concentration of plasma apo A-I estimated by densitometry scanning did not significantly differ between the groups (Table 3 
DISCUSSION
Our previous study showed that ileal, but not jejunal, apo A-I mRNA level estimated by Northern blot analysis was reduced by concurrent feeding of choles tyramine, a bile acid sequestrant, and fat-free diet did not affect the apo A-I mRNA in rats (5). More recently, Felgines et al. (14) and we (15) observed that concurrent feeding of beet fiber, which increases bile acid excretion into the feces (16) , lowered ileal apo A-I mRNA in rats. These observations suggest that a deficiency of bile acids is responsible for the depression in apo A-I mRNA in the ileum, the principal site for the active transport of bile acids, and the effect is not through the decreased absorption of dietary fat. Davidson and Glickman (6) reported that the apo A-I synthesis rate quantified by pulse labeling followed by specific immunoprecipitation was reduced by bile diversion in the ileum but not the jejunum of rats. They noted, however, that the regulation of apo A-I synthesis in the ileum was related to biliary lipid flux but not to the presence of luminal bile acids because the synthesis in this location of bile-diverted rats was not influenced by the continuous infusion of 10mM Na taurocholate for 48h, but they did not determine the apo A-I mRNA level. So in this study, we investigated the effects of bile diversion and concurrent feeding of Na taurocholate on the apo A-I mRNA level in the small intestine of rats.
In this study, Northern blot analysis revealed that the apo A-I mRNA level was not influenced by bile diversion and Na taurocholate in the jejunum, whereas in the ileum, the apo A-I mRNA was reduced by bile diversion, and feeding of the diet containing 0.4% Na taurocholate did not recover the ileal apo A-I mRNA in bile-diverted rats. These results support the findings reported by Davidson and Glickman (6) mentioned above. Thus, it may be that the ileal apo A-I synthesis is influenced by the biliary lipid flux but not bile acid at the pretranslational stage. It was not ruled out, however, that the quantity of Na taurocholate in the diet may have been insufficient to recover the apo A-I mRNA in the ileum, and that bile salts other than taurocholate may be the effector on the ileal apo A-I expression. In our preliminary experiment, biliary bile acids excretion was estimated at approximately 200mg per day (unpublished data). Therefore, the diet should have been supple mented with approximately 2% bile acid to compensate for the lack of endogenous bile acid by bile diversion. The reason why rats were fed the diet containing 0.4% Na taurocholate in this study is that diets high in Na taurocholate may suppress the food intake. Experiments to determine the effect of continuous infusion of different bile acids into the intestine on the ileal apo A-I expression in bile-diverted rats are currently in progress.
In rats, HDL is the main carrier of plasma cholesterol, and the major protein component of circulating HDL is apo A-I which is synthesized in both the liver and small intestine (2, 3) . In this study, in spite of depression of apo A-I mRNA in the ileum, the relative concentration of plasma apo A-I was not influenced by bile diversion. Bile diversion also did not affect the plasma total and HDL cholesterol concentrations. One possible explanation for these observations is that apo A-I secretion may be independent of apo A-I synthesis in the intestine. Bearnot et al. (17) showed that apo A-I secretion into rat mesenteric lymph was unchanged by bile diversion, and windmueller and wu (3) reported that the intestinal contribu tion of newly synthesized apo A-I (-50%) that entered the blood was not influenced by biliary diversion from the intestine for 16 h. Assuming that the mRNA level and synthesis rate of apo A-I in the intestine was reduced in their experimental conditions, the above possibility was strengthened by their findings. Another possibility is that the contribution of the apo A-I synthesis and secretion in the liver to the blood may be larger than that in the small intestine under our experimental conditions. Apo A-IV is the other prominent protein in circulating HDL in rats (18) . We previously observed that cholestyramine and fat-free diet lowered apo A-IV mRNA in rat jejunum, and these diets similarly tended to lower apo A-IV mRNA in the ileum, but the difference was not significant (5) . These results suggested that the expression of apo A-IV in the jejunum, the site for absorption of dietary lipids, LOWERS ILEAL APO A-I AND A-IV mRNA 351 might be modulated by dietary fat at the pretranslational level. This suggestion was supported by the previous studies that showed that apo A-IV synthesis by rat small intestine increased in response to dietary lipid and might be under pretranslational control (19) (20) (21) . In this study, however, apo A-IV mRNA was reduced by bile diversion in the ileum but not the jejunum. It is likely that bile diversion repressed fat absorption in the jejunum because of the bile acid defficiency. So the reason why the jejunal apo A-IV mRNA was not reduced in this condition is disputable. In short, it appears that the biliary element plays an important role in the ileal apo A-I gene expression at the pretranslational stage, but further investigations are necessary to determine whether the effector is the bile acid or not. The unchanged concentration of plasma apolipoprotein A-I may have resulted from the constant secretion independent of synthesis in the intestine or the larger contribution from the liver which is another principal site of apolipoprotein A-I expression.
